Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide Melanotan Mt2 for Weight Loss Peptides
Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide  Melanotan Mt2 for Weight Loss Peptides buy - large image1
Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide  Melanotan Mt2 for Weight Loss Peptides buy - image1
Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide  Melanotan Mt2 for Weight Loss Peptides buy - image2
Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide  Melanotan Mt2 for Weight Loss Peptides buy - image3
Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide  Melanotan Mt2 for Weight Loss Peptides buy - image4
Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide  Melanotan Mt2 for Weight Loss Peptides buy - image5
Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide  Melanotan Mt2 for Weight Loss Peptides buy - image6

Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide Melanotan Mt2 for Weight Loss Peptides

6989 Inquiries

Unit Price:

$125-138/G FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

gz

Packaging:

30mg/vial; 10vials/box

Price valid (until):

2029-12-29

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Tirzepatide,GHK-Cu,TB500,Nad+

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    Description  


    Sales manager:Nora
    whatsapp:+12817797656
    Email:lisa@qtsbio.com


    Product Name Retatrutide
    Appearance White powder
    CAS No. 2381089-83-2
    Application Weight Loss


       Product Function


    We are a peptide manufacturer with our own research laboratory and production line. We are committed to producing high quality research grade peptides of exceptional purity and consistency. We ensure strict quality control at every stage. The production process of lyophilized powder is mainly based on vacuum freeze-drying. Vacuum freeze-drying is used to maximize the activity and stability of the active ingredient, and the entire process from preparation to freeze-drying is carried out in our manufacturing facility, ensuring strict quality control, purity and consistency of each batch. Our commitment to excellence extends from the initial stages of peptide synthesis to packaging and delivery. We implement stringent quality control measures at every step to ensure that our products reach our customers in the purest, most consistent form.
    Explore our range of products today and enhance your research
    Klow80 is a comprehensive research blend combining four well-characterized peptides commonly investigated in laboratory models of systemic inflammation, tissue regeneration, and epithelial recovery. This formulation supports multifactorial in vitro studies involving cellular signaling and repair mechanisms.



    Product Application


      • Research material for studies on immune regulation and cellular immune function.

      • Used in investigations of thymic peptides, bioactive peptides, and related biological mechanisms.

      • Applied in biotechnology, life science research, and functional ingredient development.

    FAQ

    1. How to make an order?
    Send me message and let me know what you need with quantity , then i will calculate to you

    2. What's the lead time and shipping ways?
    We will delivery to the package by UPS, FEDEX, DHL paket and YANWEN express to you after receive your payment, it would take around 5-15 days to your address.

    3. How do i keep the peptides when i receive it ?
    Peptides in the form of lyophilized powder can be transported at room temperature by vacuum packaging, while polypeptides in the dissolved state need to be refrigerated at 2°C - 8°C. For long-term storage, peptides should be stored in the form of lyophilized powder store at -20°C or -80°C in a sealed container with desiccant, which can avoid the degradation of peptides to the greatest extent.

    4. What's the payment methods?
    We could accept pay through Wise, Bank Transfer, Alipay USDT and BTC.



       Why choose us?   


    Shop High-Quality Thymulin Peptide for Research on T Lymphocyte Differentiation and Maturation-Detailed Image 1 Shop High-Quality Thymulin Peptide for Research on T Lymphocyte Differentiation and Maturation-Detailed Image 2 Shop High-Quality Thymulin Peptide for Research on T Lymphocyte Differentiation and Maturation-Detailed Image 3

    Shop Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide  Melanotan Mt2 for Weight Loss Peptides-Detailed Image 4 Shop Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide  Melanotan Mt2 for Weight Loss Peptides-Detailed Image 5

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Tirzepatide,GHK-Cu,TB500,Nad+

    Location:

    Beijing

    Year of Establishment:

    2026

  • Inquiry History
    6989 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Palestine

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    10 MG Mar 16, 2026
    United States

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    20 MG Feb 4, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.